Summary
73 / 100 · Bulios Score
What speaks for it
- Revenue grew by 33% a year over the last 3 years.
- The share price is below the Bulios Fair Price.
What to watch
- Analysts expect revenue to fall by 39% this fiscal year.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 8.6 ZAR for 1 ZAR of yearly profit.
Valuation in detailIs it growing?
SlowlyRevenue (ZAR)
Diluted EPS (ZAR)
- Analyst estimate
Revenue grew by 26% a year over 5 years. Over the last 3 years it grew by 33% a year. For the next fiscal year analysts expect revenue to fall by 39%. Earnings per share grew by 3.0% a year over the last 3 years.
Growth in detailDoes it make money?
Income figures for the last 12 months are not available.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
High, stretched- Yield
- 7.63%
- Paid out of profit
- 66%
- Raised in a row
- 2 years
You receive $2.08 per share a year. The payout takes a large part of its profit or free cash flow.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.